Monsanto Co., adjusted current assets

US$ in millions

	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Current assets	8,651)	8,157)	10,625)	9,675)	10,077)	9,658)
Adjustments
Add: Allowance for doubtful trade receivables	78)	94)	59)	72)	68)	64)
Add: Excess of FIFO over LIFO cost¹	144)	150)	154)	160)	169)	143)
Less: Current deferred tax assets²	—)	—)	743)	635)	579)	534)
After Adjustment
Adjusted current assets	8,873)	8,401)	10,095)	9,272)	9,735)	9,331)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Excess of FIFO over LIFO cost. See details »

² Current deferred tax assets. See details »

The financial data reflects the annual values of current assets and adjusted current assets over a six-year period from 2012 to 2017.

Current Assets: The value of current assets shows a general fluctuation throughout the years. Starting at 9,658 million USD in 2012, there was a steady increase reaching a peak of 10,625 million USD in 2015. However, the following years saw a decline to 8,157 million USD in 2016 before a slight recovery to 8,651 million USD in 2017. Overall, the trend exhibits volatility with a high point in the middle of the period, followed by contraction.
Adjusted Current Assets: The adjusted current assets follow a similar pattern to current assets but present slightly lower values throughout the period. Beginning at 9,331 million USD in 2012, there is a rise to 10,095 million USD in 2015, followed by a decline to 8,401 million USD in 2016. A modest increase occurs in 2017, reaching 8,873 million USD. This trend aligns closely with that of current assets, indicating that adjustments applied do not drastically change the overall movement but moderate the figures downward.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted total assets

US$ in millions

	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Total assets	21,333)	19,736)	21,920)	21,981)	20,664)	20,224)
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)¹	458)	464)	467)	491)	435)	318)
Add: Allowance for doubtful trade receivables	78)	94)	59)	72)	68)	64)
Add: Excess of FIFO over LIFO cost²	144)	150)	154)	160)	169)	143)
Less: Current deferred tax assets³	—)	—)	743)	635)	579)	534)
Less: Noncurrent deferred tax assets⁴	564)	613)	277)	450)	454)	551)
After Adjustment
Adjusted total assets	21,449)	19,831)	21,580)	21,619)	20,303)	19,664)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

² Excess of FIFO over LIFO cost. See details »

³ Current deferred tax assets. See details »

⁴ Noncurrent deferred tax assets. See details »

Over the six-year period from August 31, 2012, to August 31, 2017, the company's total assets exhibited moderate fluctuations. The total assets initially increased from 20,224 million USD in 2012 to a peak of 21,981 million USD in 2014. This was followed by a slight decline in 2015 to 21,920 million USD and a more noticeable decrease in 2016 to 19,736 million USD. However, the total assets rebounded somewhat in 2017, reaching 21,333 million USD.

Adjusted total assets, which likely account for certain adjustments such as depreciation or other non-current asset movements, followed a similar trend. Starting at 19,664 million USD in 2012, adjusted total assets rose steadily, peaking at 21,619 million USD in 2014. This figure dropped slightly to 21,580 million USD in 2015 and more sharply to 19,831 million USD in 2016, before increasing again to 21,449 million USD in 2017.

Trend Analysis: Both total assets and adjusted total assets show a pattern of initial growth followed by a decline in 2015 and 2016 and a partial recovery in 2017.; The peak in asset values in 2014 suggests a period of asset accumulation or acquisition during that time frame, with subsequent divestitures, asset write-downs, or depreciation contributing to the decline noted in 2015 and 2016.; The recovery in 2017 indicates stabilization or renewed investment in asset growth.
Insight: The close alignment between total and adjusted assets across all years indicates that adjustments to total assets had a consistent and proportional effect throughout the period, reflecting stable asset management policies.; The asset variation pattern may imply strategic repositioning or changes in capital expenditure, warranting further investigation into operational or market factors that influenced asset composition and valuation.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted current liabilities

US$ in millions

	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Current liabilities	6,398)	6,729)	5,177)	5,112)	4,336)	4,221)
Adjustments
Less: Current deferred tax liabilities¹	—)	—)	3)	70)	38)	30)
Less: Current deferred revenues	727)	568)	370)	438)	517)	396)
Less: Current restructuring reserves	37)	227)	170)	—)	—)	—)
After Adjustment
Adjusted current liabilities	5,634)	5,934)	4,634)	4,604)	3,781)	3,795)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Current deferred tax liabilities. See details »

Current Liabilities: The current liabilities exhibited a general upward trend from 2012 to 2017. Starting at 4,221 million USD in 2012, they increased slightly in 2013 to 4,336 million USD. A more significant rise is observed in 2014, reaching 5,112 million USD, and this upward momentum continued into 2015 with a value of 5,177 million USD. A pronounced jump occurred in 2016, with current liabilities peaking at 6,729 million USD. In 2017, a slight decrease was noted, bringing the figure down to 6,398 million USD, though it remained considerably higher than in the earlier years.
Adjusted Current Liabilities: The adjusted current liabilities largely mirrored the pattern of the current liabilities but at lower absolute values throughout the period. Beginning at 3,795 million USD in 2012, there was a modest decrease to 3,781 million USD in 2013. Subsequently, values increased to 4,604 million USD in 2014 and 4,634 million USD in 2015. A strong increase was also evident in 2016, reaching 5,934 million USD. In 2017, a slight decrease to 5,634 million USD followed, similar in trend to the current liabilities but consistently reflecting a reduction relative to the unadjusted values.
Insights: The data indicates that both current liabilities and adjusted current liabilities have been on an upward trajectory over the six-year span, suggesting increasing short-term financial obligations. The adjustments appear to reduce the reported liabilities by a notable margin each year, implying that certain current liabilities are excluded or normalized in the adjusted figures. The spike in 2016 for both measures could indicate either increased operational activities, investments, or increased short-term debt. The slight reductions in 2017 may suggest efforts to improve short-term financial stability or deleverage current obligations.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted total liabilities

US$ in millions

	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Total liabilities	14,875)	15,191)	14,915)	14,067)	7,936)	8,188)
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)¹	458)	464)	467)	491)	435)	318)
Less: Current deferred tax liabilities²	—)	—)	3)	70)	38)	30)
Less: Noncurrent deferred tax liabilities³	192)	68)	340)	509)	469)	313)
Less: Deferred revenues	841)	603)	417)	485)	655)	641)
Less: Restructuring reserves	46)	244)	217)	—)	—)	—)
After Adjustment
Adjusted total liabilities	14,254)	14,740)	14,405)	13,494)	7,209)	7,522)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Current deferred tax liabilities. See details »

³ Noncurrent deferred tax liabilities. See details »

The financial data indicates a dynamic trend in the liabilities of the company over the six-year period ending August 31, 2017. Both total liabilities and adjusted total liabilities exhibit similar movements but differ in magnitude.

Total liabilities: Initially, total liabilities showed a slight decrease from 8,188 million USD in 2012 to 7,936 million USD in 2013. Subsequently, a significant upward shift occurred in 2014, with liabilities rising sharply to 14,067 million USD, nearly doubling compared to the previous year. From 2014 onward, total liabilities continued to increase but at a slower pace, reaching a peak of 15,191 million USD in 2016 before slightly declining to 14,875 million USD in 2017.
Adjusted total liabilities: Adjusted total liabilities follow a trend closely mirroring total liabilities but consistently show lower values. Starting at 7,522 million USD in 2012 and decreasing to 7,209 million USD in 2013, adjusted liabilities rose substantially in 2014 to 13,494 million USD. The increase persisted in the following years, reaching a maximum of 14,740 million USD in 2016 and then experiencing a modest reduction to 14,254 million USD in 2017.

The pronounced increase in liabilities from 2013 to 2014 may suggest notable financing activities, acquisitions, or other strategic decisions impacting the company's debt structure. The tapering growth and slight decline in liabilities after 2016 indicate possible deleveraging efforts or stabilization of the company’s obligations.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted total Monsanto Company shareowners’ equity

US$ in millions

	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Total Monsanto Company shareowners’ equity	6,438)	4,534)	6,990)	7,875)	12,559)	11,833)
Adjustments
Less: Net deferred tax assets (liabilities)¹	372)	545)	677)	506)	526)	742)
Add: Allowance for doubtful trade receivables	78)	94)	59)	72)	68)	64)
Add: Excess of FIFO over LIFO cost²	144)	150)	154)	160)	169)	143)
Add: Deferred revenues	841)	603)	417)	485)	655)	641)
Add: Restructuring reserves	46)	244)	217)	—)	—)	—)
Add: Noncontrolling interest	20)	11)	15)	39)	169)	203)
After Adjustment
Adjusted total shareowners’ equity	7,195)	5,091)	7,175)	8,125)	13,094)	12,142)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Net deferred tax assets (liabilities). See details »

² Excess of FIFO over LIFO cost. See details »

The financial data indicates fluctuations in both the total Monsanto Company shareowners’ equity and the adjusted total shareowners’ equity over the six-year period from August 31, 2012, to August 31, 2017.

Total Monsanto Company shareowners’ equity: This metric displayed an initial increasing trend from 2012 to 2013, rising from 11,833 million US dollars to 12,559 million US dollars. However, a significant decline followed in the subsequent years, with equity dropping to 7,875 million in 2014 and further diminishing to 6,990 million in 2015. The downward trend continued into 2016, reaching a low of 4,534 million US dollars. In 2017, there was a moderate recovery to 6,438 million US dollars, yet the figure remained well below the early years' levels.
Adjusted total shareowners’ equity: This value showed a similar pattern to the total shareowners’ equity. Starting at 12,142 million US dollars in 2012, the measure increased to 13,094 million US dollars in 2013. It then experienced a steep decline over the following years, falling to 8,125 million in 2014 and 7,175 million in 2015. Adjusted equity continued to shrink, reaching 5,091 million in 2016, before rebounding to 7,195 million US dollars in 2017.

In summary, both total and adjusted shareowners’ equity peaked in 2013, followed by a substantial decrease through 2016. The partial recovery observed in 2017 suggests some stabilization, though equity levels remain significantly lower compared to the peak year. This pattern may suggest impacts from operational challenges, market conditions, or strategic decisions affecting equity during this timeframe.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted capitalization table

US$ in millions

	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Short-term debt, including current portion of long-term debt	870)	1,587)	615)	233)	51)	36)
Long-term debt, excluding current portion	7,254)	7,453)	8,429)	7,528)	2,061)	2,038)
Total reported debt	8,124)	9,040)	9,044)	7,761)	2,112)	2,074)
Total Monsanto Company shareowners’ equity	6,438)	4,534)	6,990)	7,875)	12,559)	11,833)
Total reported capital	14,562)	13,574)	16,034)	15,636)	14,671)	13,907)
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)¹	458)	464)	467)	491)	435)	318)
Adjusted total debt	8,582)	9,504)	9,511)	8,252)	2,547)	2,392)
Adjustments to Equity
Less: Net deferred tax assets (liabilities)²	372)	545)	677)	506)	526)	742)
Add: Allowance for doubtful trade receivables	78)	94)	59)	72)	68)	64)
Add: Excess of FIFO over LIFO cost³	144)	150)	154)	160)	169)	143)
Add: Deferred revenues	841)	603)	417)	485)	655)	641)
Add: Restructuring reserves	46)	244)	217)	—)	—)	—)
Add: Noncontrolling interest	20)	11)	15)	39)	169)	203)
Adjusted total shareowners’ equity	7,195)	5,091)	7,175)	8,125)	13,094)	12,142)
After Adjustment
Adjusted total capital	15,777)	14,595)	16,686)	16,377)	15,641)	14,534)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Net deferred tax assets (liabilities). See details »

³ Excess of FIFO over LIFO cost. See details »

The financial data demonstrates several notable trends over the six-year period from 2012 to 2017. The company experienced significant fluctuations in both debt levels and equity, affecting its overall capital structure.

Total reported debt: The total reported debt increased substantially from 2012 through 2015, rising from US$2,074 million to a peak of US$9,044 million in 2015. After reaching this peak, the debt level remained relatively stable, with a slight decrease to US$8,124 million by 2017.
Total Monsanto Company shareowners’ equity: Shareowners’ equity showed a declining trend over the period. It decreased steadily from US$11,833 million in 2012 to a low of US$4,534 million in 2016 before partially recovering to US$6,438 million in 2017. This indicates a weakening equity base, which may have resulted from various operational or financial factors during this period.
Total reported capital: Total reported capital, which combines debt and equity, showed moderate growth from US$13,907 million in 2012 to US$16,034 million in 2015. However, it declined sharply to US$13,574 million in 2016, followed by an increase to US$14,562 million in 2017. The fluctuations reflect the interplay between rising debt levels and diminishing equity.
Adjusted total debt: The adjusted total debt mirrored the pattern of total reported debt but consistently presented higher values, starting at US$2,392 million in 2012 and peaking at US$9,511 million in 2015. It then slightly decreased to US$8,582 million in 2017. The adjustment suggests the inclusion of additional liabilities or reclassification that emphasizes a higher debt load throughout the period.
Adjusted total shareowners’ equity: Adjusted equity followed a decline similar to the unadjusted equity, falling from US$12,142 million in 2012 to US$5,091 million in 2016. A notable recovery occurred in 2017, with equity increasing to US$7,195 million. The adjustment may account for revaluations or inclusion of equity components not captured in the reported figures, yet the overall downward trend reflects pressure on the company’s equity base.
Adjusted total capital: The adjusted total capital showed consistent growth from US$14,534 million in 2012 to US$16,686 million in 2015, followed by a decline to US$14,595 million in 2016 before increasing to US$15,777 million in 2017. This trend aligns with the movements in adjusted debt and equity, showing volatility but generally a relatively high capital base.

In summary, the data reveals a period of increasing indebtedness, accompanied by a weakening equity position, especially notable between 2012 and 2016. The peak debt levels in 2015 and 2016 suggest significant leverage, which may pose financial risks. The partial recovery in equity and capital in 2017 indicates a possible stabilization or strategic financial restructuring during that year. Overall, the company’s capital structure shifted towards heavier reliance on debt financing over the analyzed period, with corresponding impacts on equity values.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted net sales

US$ in millions

12 months ended:	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Net sales	14,640)	13,502)	15,001)	15,855)	14,861)	13,504)
Adjustment
Add: Increase (decrease) in deferred revenues	238)	186)	(68)	(170)	14)	(69)
After Adjustment
Adjusted net sales	14,878)	13,688)	14,933)	15,685)	14,875)	13,435)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

The financial data over the period from August 31, 2012, to August 31, 2017, demonstrates notable fluctuations in both net sales and adjusted net sales.

Net Sales: The net sales exhibited a general upward trend from 2012 to 2014, increasing from 13,504 million US dollars to a peak of 15,855 million US dollars in 2014. Following this peak, there was a decline in 2015 and 2016, with net sales decreasing to 15,001 million and 13,502 million US dollars respectively. However, in 2017, net sales recovered, rising again to 14,640 million US dollars.
Adjusted Net Sales: The adjusted net sales follow a pattern similar to net sales, starting at 13,435 million US dollars in 2012 and reaching 15,685 million US dollars in 2014. Thereafter, a decline is observed in 2015 and 2016, reaching 13,688 million US dollars in 2016. The adjusted net sales increase again in 2017 to 14,878 million US dollars.
Comparative Analysis: Both net sales and adjusted net sales consistently show close values throughout the years, indicating that adjustments have minor effects on the overall sales figures. The peak in 2014 followed by a decline over the subsequent two years suggests possible market challenges or internal factors affecting sales. The recovery in 2017 indicates an improvement or stabilization in sales performance.
Overall Trends: The data reflects a cyclical pattern with growth, decline, and recovery phases within the five-year span. This suggests the company faced volatility in its sales, with external or internal influences impacting performance during 2015 and 2016, before a resurgence in 2017.

AI Ask an analyst for more

Download chart

Monsanto Co., adjusted net income attributable to Monsanto Company

US$ in millions

12 months ended:	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012
As Reported
Net income attributable to Monsanto Company	2,260)	1,336)	2,314)	2,740)	2,482)	2,045)
Adjustments
Add: Deferred income tax expense (benefit)¹	46)	28)	(288)	(45)	126)	241)
Add: Increase (decrease) in allowance for doubtful trade receivables	(16)	35)	(13)	4)	4)	(34)
Add: Increase (decrease) in LIFO reserve²	(6)	(4)	(6)	(9)	26)	(43)
Add: Increase (decrease) in deferred revenues	238)	186)	(68)	(170)	14)	(69)
Add: Increase (decrease) in restructuring reserves	(198)	27)	217)	—)	—)	(24)
Less: Income on discontinued operations	13)	17)	28)	13)	11)	6)
Add: Other comprehensive income (loss), net of tax	382)	(8)	(1,691)	174)	(269)	(960)
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest	14)	(24)	7)	32)	16)	8)
After Adjustment
Adjusted net income	2,707)	1,559)	444)	2,713)	2,388)	1,158)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

¹ Deferred income tax expense (benefit). See details »

² Increase (decrease) in LIFO reserve. See details »

The financial data reveals distinct trends in both net income attributable to Monsanto Company and adjusted net income over the six-year period from 2012 to 2017.

Net income attributable to Monsanto Company: The net income exhibited an overall upward trajectory from 2012 through 2014, rising from 2,045 million US dollars to a peak of 2,740 million US dollars. However, it declined noticeably in 2015 to 2,314 million US dollars and further dropped significantly in 2016 to 1,336 million US dollars. In 2017, the net income rebounded substantially to 2,260 million US dollars, approaching levels seen in previous years but still below the 2014 peak.
Adjusted net income: Adjusted net income shows more volatility. It increased from 1,158 million US dollars in 2012 to 2,388 million in 2013 and further to 2,713 million in 2014. A sharp decrease occurred in 2015, falling drastically to 444 million, representing the lowest point in the observed period. This was followed by a recovery phase in 2016 and 2017, where adjusted net income rose to 1,559 million and then to 2,707 million, nearly reaching the previous highs of 2014.

Overall, both net income and adjusted net income demonstrate growth trends in the early years, followed by a pronounced dip in 2015, which affected both metrics more dramatically in the adjusted figures. The recovery observed in 2016 and 2017 indicates improved financial performance heading towards the end of the timeframe analyzed. The adjusted net income's significant fluctuation in 2015 suggests the presence of one-time or non-recurring items impacting reported results during that year.

AI Ask an analyst for more

Download chart

Monsanto Co. (NYSE:MON)

Adjustments to Financial Statements

Adjustments to Current Assets

Adjustments to Total Assets

Adjustments to Current Liabilities

Adjustments to Total Liabilities

Adjustments to Stockholders’ Equity

Adjustments to Capitalization Table

Adjustments to Revenues

Adjustments to Reported Income